RCKT Stock-Based Compensation
Rocket Pharmaceuticals Inc · Stock-Based Compensation
RCKT Stock-Based Compensation
Latest reported$31.78Mperiod ending
RCKT Stock-Based Comp ($486.00K → $31.78M)
Annual stock-based compensation
High-resolution chart · PNG
RCKT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 37,059,000 | |
| 43,920,000 | |
| 39,406,000 | |
| 31,009,000 | |
| 29,237,000 | |
| 18,567,000 | |
| 13,371,000 | |
| 13,601,000 | |
| 4,036,000 | |
| 2,909,000 | |
| 2,380,000 | |
| 177,000 | |
| -148,000 | |
| 486,000 |